3zeb: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='3zeb' size='340' side='right'caption='[[3zeb]], [[Resolution|resolution]] 2.20Å' scene=''> | <StructureSection load='3zeb' size='340' side='right'caption='[[3zeb]], [[Resolution|resolution]] 2.20Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3zeb]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | <table><tr><td colspan='2'>[[3zeb]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli_BL21(DE3) Escherichia coli BL21(DE3)]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ZEB OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3ZEB FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BNG:B-NONYLGLUCOSIDE'>BNG</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=SV1:2-PHENYLETHYL+2-(4-AZANYL-2-METHANOYL-PHENYL)ETHANOATE'>SV1</scene | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BNG:B-NONYLGLUCOSIDE'>BNG</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=SV1:2-PHENYLETHYL+2-(4-AZANYL-2-METHANOYL-PHENYL)ETHANOATE'>SV1</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3zeb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3zeb OCA], [https://pdbe.org/3zeb PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3zeb RCSB], [https://www.ebi.ac.uk/pdbsum/3zeb PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3zeb ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3zeb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3zeb OCA], [https://pdbe.org/3zeb PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3zeb RCSB], [https://www.ebi.ac.uk/pdbsum/3zeb PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3zeb ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[https://www.uniprot.org/uniprot/GLPG_ECOLI GLPG_ECOLI] Rhomboid-type serine protease that catalyzes intramembrane proteolysis.<ref>PMID:17099694</ref> <ref>PMID:16216077</ref> | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 26: | Line 26: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Brouwer AJ]] | |||
[[Category: Brouwer | [[Category: Kuettler EV]] | ||
[[Category: Kuettler | [[Category: Liskamp RMJ]] | ||
[[Category: Liskamp | [[Category: Verhelst SHL]] | ||
[[Category: Verhelst | [[Category: Vinothkumar KR]] | ||
[[Category: Vinothkumar | [[Category: Voskya O]] | ||
[[Category: Voskya | |||
Latest revision as of 14:00, 20 December 2023
A complex of GlpG with isocoumarin inhibitor covalently bonded to serine 201 and histidine 150A complex of GlpG with isocoumarin inhibitor covalently bonded to serine 201 and histidine 150
Structural highlights
FunctionGLPG_ECOLI Rhomboid-type serine protease that catalyzes intramembrane proteolysis.[1] [2] Publication Abstract from PubMedRhomboid proteases are evolutionary conserved intramembrane serine proteases. Because of their emerging role in many important biological pathways, rhomboids are potential drug targets. Unfortunately, few chemical tools are available for their study. Here, we describe a mass spectrometry-based assay to measure rhomboid substrate cleavage and inhibition. We have identified isocoumarin inhibitors and developed activity-based probes for rhomboid proteases. The probes can distinguish between active and inactive rhomboids due to covalent, reversible binding of the active-site serine and stable modification of a histidine residue. Finally, the structure of an isocoumarin-based inhibitor with Escherichia coli rhomboid GlpG uncovers an unusual mode of binding at the active site and suggests that the interactions between the 3-substituent on the isocoumarin inhibitor and hydrophobic residues on the protease reflect S' subsite binding. Overall, these probes represent valuable tools for rhomboid study, and the structural insights may facilitate future inhibitor design. Activity-based probes for rhomboid proteases discovered in a mass spectrometry-based assay.,Vosyka O, Vinothkumar KR, Wolf EV, Brouwer AJ, Liskamp RM, Verhelst SH Proc Natl Acad Sci U S A. 2013 Jan 28. PMID:23359682[3] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||